- Home
- ATNI vs OLMA Comparison
ATNI vs OLMA Comparison
Compare ATNI & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNI
- OLMA
- Stock Information
- Founded
- ATNI 1987
- OLMA 2006
- Country
- ATNI United States
- OLMA United States
- Employees
- ATNI N/A
- OLMA N/A
- Industry
- ATNI Telecommunications Equipment
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- ATNI Telecommunications
- OLMA Health Care
- Exchange
- ATNI Nasdaq
- OLMA Nasdaq
- Market Cap
- ATNI 267.1M
- OLMA 289.0M
- IPO Year
- ATNI 1991
- OLMA 2020
- Fundamental
- Price
- ATNI $15.03
- OLMA $4.49
- Analyst Decision
- ATNI Strong Buy
- OLMA Strong Buy
- Analyst Count
- ATNI 1
- OLMA 4
- Target Price
- ATNI $30.00
- OLMA $24.50
- AVG Volume (30 Days)
- ATNI 52.8K
- OLMA 688.0K
- Earning Date
- ATNI 07-23-2025
- OLMA 05-13-2025
- Dividend Yield
- ATNI 6.76%
- OLMA N/A
- EPS Growth
- ATNI N/A
- OLMA N/A
- EPS
- ATNI N/A
- OLMA N/A
- Revenue
- ATNI $721,575,000.00
- OLMA N/A
- Revenue This Year
- ATNI $2.03
- OLMA N/A
- Revenue Next Year
- ATNI $1.59
- OLMA N/A
- P/E Ratio
- ATNI N/A
- OLMA N/A
- Revenue Growth
- ATNI N/A
- OLMA N/A
- 52 Week Low
- ATNI $13.76
- OLMA $2.86
- 52 Week High
- ATNI $33.72
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- ATNI 37.69
- OLMA 48.75
- Support Level
- ATNI $13.76
- OLMA $4.80
- Resistance Level
- ATNI $14.79
- OLMA $5.61
- Average True Range (ATR)
- ATNI 0.52
- OLMA 0.40
- MACD
- ATNI 0.10
- OLMA -0.01
- Stochastic Oscillator
- ATNI 29.17
- OLMA 48.39
About ATNI ATN International Inc.
ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.